| Biological process |
| GO:0002181 |
Cytoplasmic translation |
3.60E−07 |
| GO:0006412 |
Translation |
8.90E−07 |
| GO:0042632 |
Cholesterol homeostasis |
2.20E−03 |
| GO:0033344 |
Cholesterol efflux |
2.70E−03 |
| GO:0010873 |
Positive regulation of cholesterol esterification |
2.80E−03 |
| GO:0034380 |
High-density lipoprotein particle assembly |
3.70E−03 |
| GO:0000463 |
Maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) |
4.70E−03 |
| GO:0043691 |
Reverse cholesterol transport |
7.10E−03 |
| GO:0033700 |
Phospholipid efflux |
8.40E−03 |
| GO:0098779 |
Mitophagy in response to mitochondrial depolarization |
1.00E−02 |
| GO:0042157 |
Lipoprotein metabolic process |
1.30E−02 |
| GO:0019433 |
Triglyceride catabolic process |
1.50E−02 |
| GO:0006904 |
Vesicle docking involved in exocytosis |
2.30E−02 |
| GO:0000027 |
Ribosomal large subunit assembly |
2.30E−02 |
| GO:0018158 |
Protein oxidation |
2.30E−02 |
| GO:0006403 |
RNA localization |
2.30E−02 |
| GO:0010628 |
Positive regulation of gene expression |
2.60E−02 |
| GO:0001843 |
Neural tube closure |
3.10E−02 |
| GO:0006695 |
Cholesterol biosynthetic process |
3.20E−02 |
| GO:0051028 |
mRNA transport |
3.20E−02 |
| GO:0042921 |
Glucocorticoid receptor signaling pathway |
3.50E−02 |
| GO:0010903 |
Negative regulation of very-low-density lipoprotein particle remodeling |
3.50E−02 |
| GO:0006046 |
N-acetylglucosamine catabolic process |
3.50E−02 |
| GO:1901998 |
Toxin transport |
3.70E−02 |
| GO:0006888 |
ER to Golgi vesicle-mediated transport |
3.80E−02 |
| GO:0018206 |
Peptidyl-methionine modification |
4.60E−02 |
| GO:0042159 |
Lipoprotein catabolic process |
4.60E−02 |
| GO:0042158 |
Lipoprotein biosynthetic process |
4.60E−02 |
| Cellular component |
| GO:0022625 |
Cytosolic large ribosomal subunit |
4.00E−12 |
| GO:0070062 |
Extracellular exosome |
2.70E−08 |
| GO:0005925 |
Focal adhesion |
1.30E−05 |
| GO:0016020 |
Membrane |
1.70E−04 |
| GO:0034361 |
Very-low-density lipoprotein particle |
3.60E−04 |
| GO:0005840 |
Ribosome |
8.30E−04 |
| GO:0022627 |
Cytosolic small ribosomal subunit |
9.90E−04 |
| GO:0042627 |
Chylomicron |
3.30E−03 |
| GO:0072562 |
Blood microparticle |
9.70E−03 |
| GO:0034363 |
Intermediate-density lipoprotein particle |
3.30E−02 |
| GO:0005730 |
Nucleolus |
3.80E−02 |
| GO:0008180 |
COP9 signalosome |
4.60E−02 |
| GO:0005737 |
Cytoplasm |
4.70E−02 |
| Molecular function |
| GO:0003735 |
Structural constituent of ribosome |
5.20E−10 |
| GO:0003723 |
Poly(A) RNA binding |
2.90E−09 |
| GO:0017127 |
Cholesterol transporter activity |
3.30E−04 |
| GO:0019843 |
rRNA binding |
5.20E−04 |
| GO:0060228 |
Phosphatidylcholine-sterol O-acyltransferase activator activity |
1.40E−03 |
| GO:0003729 |
mRNA binding |
6.90E−03 |
| GO:0005543 |
Phospholipid binding |
1.70E−02 |
| GO:0003743 |
Translation initiation factor activity |
2.10E−02 |
| GO:0003723 |
RNA binding |
3.50E−02 |
| GO:0008035 |
High-density lipoprotein particle binding |
3.50E−02 |
| GO:0070653 |
High-density lipoprotein particle receptor binding |
3.50E−02 |
| GO:0015485 |
Cholesterol binding |
4.60E−02 |
